NCT06576843 - INDV-6001 Multiple-Dose Pharmacokinetic Study | Biotech Hunter

Enrollment

122

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Moderate to Severe Opioid Use Disorder

Interventions

DRUG

INDV-6001

Extended-release subcutaneous injection

DRUG

Suboxone

Oral sublingual film

DRUG

Sublocade

Extended-release subcutaneous injection

Trial Locations (11)

Richmond Behavioral Associates, Staten Island

Innovative Clinical Research, Inc., Miami Lakes

Precise Research Centers, Flowood

Midwest Clinical Research, Dayton

Chicago Clinical Research Institute Inc., Chicago

Pillar Clinical Research, Richardson

Insite Clinical Research, LLC, DeSoto

Memorial Hermann Village, Houston

Progressive Clinical Research, Bountiful

Artemis Institute for Clinical Research, San Diego

Hassman Research Institute (Cenexel HRI - Marlton), Marlton